+Compare
MRK
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
253.86B

MRK Price Prediction, Merck & Co AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for MRK with price predictions
07:00 PM EST Dec 05, 2023

MRK in upward trend: price rose above 50-day moving average on December 01, 2023

MRK moved above its 50-day moving average on December 01, 2023 date and that indicates a change from a downward trend to an upward trend. In of 60 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 30, 2023. You may want to consider a long position or call options on MRK as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MRK just turned positive on November 30, 2023. Looking at past instances where MRK's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRK advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MRK moved out of overbought territory on December 06, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MRK broke above its upper Bollinger Band on December 01, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MRK entered a downward trend on December 04, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.154) is normal, around the industry mean (5.180). P/E Ratio (55.556) is within average values for comparable stocks, (34.823). Projected Growth (PEG Ratio) (0.803) is also within normal values, averaging (3.115). Dividend Yield (0.029) settles around the average of (0.029) among similar stocks. P/S Ratio (4.305) is also within normal values, averaging (3.589).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MRK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I. Advisor
published Earnings

MRK is expected to report earnings to fall 94.56% to 11 cents per share on February 01

Merck & Co MRK Stock Earnings Reports
Q4'23
Est.
$0.12
Q3'23
Beat
by $0.18
Q2'23
Beat
by $0.12
Q1'23
Beat
by $0.05
Q4'22
Beat
by $0.09
The last earnings report on October 26 showed earnings per share of $2.13, beating the estimate of $1.95. With 1.25M shares outstanding, the current market capitalization sits at 253.86B.
A.I.Advisor
published Dividends

MRK paid dividends on October 06, 2023

Merck & Co MRK Stock Dividends
А dividend of $0.73 per share was paid with a record date of October 06, 2023, and an ex-dividend date of September 14, 2023. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NASDAQ:LLY), Johnson & Johnson (NASDAQ:JNJ), Merck & Co (NASDAQ:MRK), ABBVIE (NASDAQ:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NASDAQ:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NASDAQ:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 79.67B. The market cap for tickers in the group ranges from 72.83K to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -8%. CMOPF experienced the highest price growth at 17%, while MIRA experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was 43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 27
P/E Growth Rating: 57
Price Growth Rating: 52
SMR Rating: 57
Profit Risk Rating: 69
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
69000
Web
https://www.merck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARDX5.140.12
+2.49%
Ardelyx
AEP80.361.05
+1.32%
American Electric Power Company
RENB3.360.03
+0.90%
Renovaro Biosciences
LYFT12.21-0.03
-0.25%
Lyft
FGH1.38-0.16
-10.39%
FG Group Holdings

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with NVS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-0.56%
NVS - MRK
50%
Loosely correlated
+0.08%
JNJ - MRK
47%
Loosely correlated
-1.22%
GILD - MRK
43%
Loosely correlated
+0.46%
LLY - MRK
36%
Loosely correlated
+0.19%
ABBV - MRK
34%
Loosely correlated
+1.25%
More